Actively Recruiting
Diagnostic Efficacy of Connected WAtch ECG Versus External Holter ECG
Led by L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône · Updated on 2025-04-08
81
Participants Needed
1
Research Sites
96 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Palpitations are a frequent reason for consultation (16% of total volume) and management in the emergency department. Conventional diagnostic management in our establishment is based on a 48-hour external ECG holter, combined with a stress test if symptoms are triggered by physical activity. The diagnostic difficulty lies in the frequency and duration of this transient symptom. At the time of consultation, the patient is often asymptomatic. The initial strategy is to demonstrate an electrocardiographic trace during the attack, in order to adapt management to the chosen etiology. The HOLTER ECG is the gold standard, but it is not very cost-effective due to the infrequent and random nature of the onset of symptoms. The advent of accessible connected tools such as connected watches seems to be an interesting alternative for acquiring a per-critical trace of symptoms. They are widely adopted by the general population, with ease of use by the individual and long monitoring times. The main aim of the study is to establish the diagnostic cost-effectiveness of one or other of the two diagnostic strategies (rate of identification of the causal arrhythmia) at 6 months from the cardiological consultation.
CONDITIONS
Official Title
Diagnostic Efficacy of Connected WAtch ECG Versus External Holter ECG
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients consulting for palpitations without a previous arrhythmia diagnosis or with different current symptoms
- Palpitations requiring cardiology consultation or emergency treatment
- No suggestive diagnosis on resting 12-lead ECG
- Non-contributory stress test if symptoms occur during exercise
- Willingness to wear the connected watch except during charging
- Use of compatible smartphone or tablet with internet access
- Affiliated with a social security system
- Signed informed consent form
You will not qualify if you...
- Refusal to wear or use the connected watch provided
- Inability to use the connected watch or lack of understanding
- No smartphone available
- Having an implantable device (pacemaker, ICD)
- Known and treated arrhythmia with identical symptoms
- Heart disease requiring implantable device for prevention
- Associated syncope
- Clear non-cardiac cause of symptoms
- Pregnant or breastfeeding
- Unable to complete follow-up due to geographic, language, social, or psychological reasons
- Participation in another interfering clinical study
- Under guardianship or deprived of liberty
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hopitaux Nord-Ouest Villefranche Sur Saone
Gleizé, France, 69400
Actively Recruiting
Research Team
O
OLIVIER LE VAVASSEUR, MEDECINE
CONTACT
C
COLINE PERRIER, ARC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here